## Outcome

Describe the user-visible or engineering outcome and its authoritative owner.

## Portfolio readiness transition

Read `docs/portfolio-readiness.md`. State the highest-risk unproven boundary addressed, its blocker class before this PR, the exact evidence supporting the transition, remaining unproven boundaries, and the downstream trustworthy composed capability newly unblocked.

Blocker class: security/correctness/authority defect / missing foundational capability / qualification-evidence-infrastructure gap / missing vertical composition proof / measured performance-concurrency bottleneck / convenience-API expansion / community-presentation polish.

- [ ] Architecture disposition, implementation status, qualification/support status, and priority remain separate.
- [ ] Missing Hyper-V/KVM/host/CI or other qualification evidence is not represented as a code defect without independent falsification.
- [ ] Performance/concurrency work is tied to a real workload or measured bottleneck rather than a theoretical ceiling.
- [ ] Once the boundary was sufficiently specified, a thin executable proof through production contracts was preferred over speculative layering.
- [ ] Any broad credential-bearing, multi-workstation, multi-user, publication-capable, elevated, or remote-execution deployment impact identifies the required independent security-review gate.

## Trust and LEGO boundaries

Identify affected capabilities, security/recovery boundaries, provider adapters, and substitution/deletion effects. Confirm that repository-controlled execution cannot gain host authority or a host fallback.

## Validation

List exact checks and evidence. State explicitly which real Hyper-V/KVM or other environment-dependent checks were not run.

- [ ] I read the applicable `AGENTS.md`, `docs/portfolio-readiness.md`, and `specs/DB-*` authority.
- [ ] I preserved provider-neutral core vocabulary and kept provider details inside adapters.
- [ ] I added or updated tests for changed behavior and failure/recovery paths.
- [ ] I did not add secrets, private paths, or sensitive evidence.
